YU94202A - Ne-nukleozidni inhibitori reverzne transkriptaze - Google Patents
Ne-nukleozidni inhibitori reverzne transkriptazeInfo
- Publication number
- YU94202A YU94202A YU94202A YUP94202A YU94202A YU 94202 A YU94202 A YU 94202A YU 94202 A YU94202 A YU 94202A YU P94202 A YUP94202 A YU P94202A YU 94202 A YU94202 A YU 94202A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- reverse transcriptase
- transcriptase inhibitors
- nucleoside reverse
- group
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Prpremljena su jedinjenja opšte formule I: u kojoj R2 jeste odabran iz grupe koja se sastoji od H, F, Cl (C1-4) alkil, (C3-4) cikloalkil i CF3; R4 je H ili Me; R5 je H, Me ili Et, uz uslov da R4 i R5 nisu oba Me, a alko R4 jeste Me tada R5 ne može biti Et; R11 je Et, ciklopropil, propil, izopropil ili izobutil grupa; a Q je odabrano iz grupe koja se sastoji od (II), (III), (IV), i (V) i njihove farmaceutski prihvatljive soli, kao inhibotori reverzne transkriptaze HIVa, divljeg tipa i nekoliko mutiranih sojeva.[Provided are compounds of general formula (I), wherein R2 is selected from the group consisting of H, F, Cl, (C1-4) alkyl, (C3-4) cycloalkyl and CF3; R4 is H or Me; R5 is H, Me or Et, with the proviso that R4 and R5 are not both Me, and if R4 is Me then R5 cannot be Et; R11 is Et, cyclopropyl, propyl, isopropyl, or isobutyl; and Q is selected from the group consisting of (II), (III), (IV) and (V); and pharmaceutically acceptable salts thereof, as inhibitors of HIV reverse transcriptase, wild-type and several mutant strains.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21232900P | 2000-06-16 | 2000-06-16 | |
| US25663800P | 2000-12-18 | 2000-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU94202A true YU94202A (sh) | 2005-11-28 |
Family
ID=26907019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU94202A YU94202A (sh) | 2000-06-16 | 2001-06-14 | Ne-nukleozidni inhibitori reverzne transkriptaze |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6420359B1 (sh) |
| EP (1) | EP1294720B1 (sh) |
| JP (1) | JP3923894B2 (sh) |
| KR (1) | KR20030017540A (sh) |
| CN (1) | CN1178939C (sh) |
| AR (1) | AR028958A1 (sh) |
| AT (1) | ATE322492T1 (sh) |
| AU (2) | AU7037001A (sh) |
| BG (1) | BG107348A (sh) |
| BR (1) | BR0102377A (sh) |
| CA (1) | CA2411766C (sh) |
| CZ (1) | CZ20024114A3 (sh) |
| DE (1) | DE60118560T2 (sh) |
| DK (1) | DK1294720T3 (sh) |
| EA (1) | EA005598B1 (sh) |
| EE (1) | EE200200690A (sh) |
| ES (1) | ES2261433T3 (sh) |
| HK (1) | HK1057558A1 (sh) |
| HR (1) | HRP20021003A2 (sh) |
| HU (1) | HUP0301105A2 (sh) |
| IL (1) | IL152819A0 (sh) |
| MX (1) | MXPA02012205A (sh) |
| MY (1) | MY130375A (sh) |
| NO (1) | NO323830B1 (sh) |
| NZ (1) | NZ523549A (sh) |
| PE (1) | PE20020083A1 (sh) |
| PL (1) | PL360370A1 (sh) |
| PT (1) | PT1294720E (sh) |
| SA (1) | SA01220202B1 (sh) |
| SK (1) | SK17722002A3 (sh) |
| TW (1) | TWI270547B (sh) |
| UA (1) | UA74834C2 (sh) |
| UY (1) | UY26767A1 (sh) |
| WO (1) | WO2001096338A1 (sh) |
| YU (1) | YU94202A (sh) |
| ZA (1) | ZA200209807B (sh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716836B2 (en) | 2001-03-22 | 2004-04-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6673791B2 (en) | 2001-07-30 | 2004-01-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6706706B2 (en) | 2002-03-27 | 2004-03-16 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| US6806265B2 (en) * | 2002-05-16 | 2004-10-19 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| US6759533B2 (en) * | 2002-06-28 | 2004-07-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors |
| US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| CA2510143A1 (en) * | 2002-12-16 | 2004-07-01 | Boehringer Ingelheim International Gmbh | Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450, such as protease inhibitors |
| WO2004087140A1 (en) * | 2003-03-27 | 2004-10-14 | Boehringer Ingelheim International Gmbh | Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
| US7309700B2 (en) * | 2004-04-02 | 2007-12-18 | Boehringer Ingelheim International Gmbh | Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one |
| US20060025480A1 (en) | 2004-08-02 | 2006-02-02 | Boehringer Ingelheim International Gmbh | Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors |
| US7151174B2 (en) * | 2004-11-05 | 2006-12-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor |
| WO2007067844A1 (en) * | 2005-12-05 | 2007-06-14 | Boehringer Ingelheim International Gmbh | Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
| EP2085390A1 (en) * | 2008-01-31 | 2009-08-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| JP5643290B2 (ja) * | 2009-04-09 | 2014-12-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｈｉｖ複製の阻害薬 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| US5705499A (en) * | 1995-10-06 | 1998-01-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection |
-
2001
- 2001-05-30 TW TW090113049A patent/TWI270547B/zh not_active IP Right Cessation
- 2001-06-12 BR BR0102377-2A patent/BR0102377A/pt not_active IP Right Cessation
- 2001-06-12 US US09/879,447 patent/US6420359B1/en not_active Expired - Lifetime
- 2001-06-13 UY UY26767A patent/UY26767A1/es not_active Application Discontinuation
- 2001-06-14 NZ NZ523549A patent/NZ523549A/en unknown
- 2001-06-14 YU YU94202A patent/YU94202A/sh unknown
- 2001-06-14 AT AT01949124T patent/ATE322492T1/de active
- 2001-06-14 DE DE60118560T patent/DE60118560T2/de not_active Expired - Lifetime
- 2001-06-14 AU AU7037001A patent/AU7037001A/xx active Pending
- 2001-06-14 PE PE2001000560A patent/PE20020083A1/es not_active Application Discontinuation
- 2001-06-14 ES ES01949124T patent/ES2261433T3/es not_active Expired - Lifetime
- 2001-06-14 PT PT01949124T patent/PT1294720E/pt unknown
- 2001-06-14 UA UA2003010387A patent/UA74834C2/uk unknown
- 2001-06-14 EA EA200201255A patent/EA005598B1/ru not_active IP Right Cessation
- 2001-06-14 AU AU2001270370A patent/AU2001270370B2/en not_active Ceased
- 2001-06-14 EP EP01949124A patent/EP1294720B1/en not_active Expired - Lifetime
- 2001-06-14 MX MXPA02012205A patent/MXPA02012205A/es active IP Right Grant
- 2001-06-14 CN CNB018112692A patent/CN1178939C/zh not_active Expired - Fee Related
- 2001-06-14 HU HU0301105A patent/HUP0301105A2/hu unknown
- 2001-06-14 EE EEP200200690A patent/EE200200690A/xx unknown
- 2001-06-14 JP JP2002510480A patent/JP3923894B2/ja not_active Expired - Lifetime
- 2001-06-14 DK DK01949124T patent/DK1294720T3/da active
- 2001-06-14 KR KR1020027017173A patent/KR20030017540A/ko active IP Right Grant
- 2001-06-14 PL PL36037001A patent/PL360370A1/xx not_active Application Discontinuation
- 2001-06-14 CZ CZ20024114A patent/CZ20024114A3/cs unknown
- 2001-06-14 WO PCT/CA2001/000890 patent/WO2001096338A1/en active IP Right Grant
- 2001-06-14 SK SK1772-2002A patent/SK17722002A3/sk not_active Application Discontinuation
- 2001-06-14 CA CA002411766A patent/CA2411766C/en not_active Expired - Fee Related
- 2001-06-14 IL IL15281901A patent/IL152819A0/xx unknown
- 2001-06-15 AR ARP010102870A patent/AR028958A1/es unknown
- 2001-06-15 MY MYPI20012820A patent/MY130375A/en unknown
- 2001-07-07 SA SA01220202A patent/SA01220202B1/ar unknown
-
2002
- 2002-12-03 ZA ZA200209807A patent/ZA200209807B/en unknown
- 2002-12-03 BG BG107348A patent/BG107348A/bg unknown
- 2002-12-05 NO NO20025844A patent/NO323830B1/no unknown
- 2002-12-13 HR HR20021003A patent/HRP20021003A2/hr not_active Application Discontinuation
-
2004
- 2004-01-21 HK HK04100468A patent/HK1057558A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU94202A (sh) | Ne-nukleozidni inhibitori reverzne transkriptaze | |
| SI1585739T1 (sl) | Substituirani arilciklopropilacetamidi kot aktivatorji glukokinaze | |
| AR077416A2 (es) | Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos | |
| NO20045152L (no) | Ikke-nukleosid-reverstranskriptaseinhibitorer | |
| IL219131A0 (en) | S-triazolyl mercaptoacetanildes as inhibitors of hiv reverse transcriptase | |
| CA2288910A1 (en) | Pyrazolopyrimidinones for sexual dysfunction | |
| SE0202463D0 (sv) | Novel compounds | |
| AR054386A1 (es) | Moduladores de quinasas con estructuras de alquiloquinolina y alquilquinazolina | |
| NO931366D0 (no) | 1,2,4-oksadiazolylfenoksyalkylisoksazoler og deres anvendelse som antivirale midler | |
| AU2003303944A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| SE9802974D0 (sv) | New crystalline forms | |
| MX2021011286A (es) | Compuestos de heterociclil(fenil)metanol útiles en el tratamiento de la hiperglucemia. | |
| TW200616933A (en) | Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors | |
| WO2002024663A3 (en) | Pyrimidine compounds and their use | |
| RS50229B (sr) | Analozi vitamina d3 | |
| DE60005689D1 (de) | Neue aminobenzophenone | |
| CA2412596A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| GB9907458D0 (en) | Processes for preparing pesticidal intermediates | |
| YU6396A (sh) | Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija | |
| MXPA03007966A (es) | Inhibidores de transcriptasa reversa sin nucleosido. | |
| TR200100070A2 (tr) | Bileşim | |
| UA89970C2 (ru) | Гетероциклические соединения и активаторы рецептора тромбопоэтина |